logo
Plus   Neg
Share
Email

DENTSPLY Int'l. Q1 GAAP Profit Slips, Adj. EPS Up - Quick Facts

DENTSPLY International Inc. (XRAY) posted lower first-quarter net income attributable to the company of $53.3 million, or $0.37 per share, compared with $69.1 million, or $0.48 per share in the prior-year quarter.

However, excluding non-GAAP items, quarterly adjusted earnings per share were $0.52, higher than $0.50 a year earlier. On average, 14 analysts polled by Thomson Reuters expected earnings per share of $0.52 for the quarter. Analysts' estimates typically exclude one-time items.

Net sales in the recent quarter increased 25.6% to $716.4 million from $570.5 million last year, whereas 10 analysts estimated revenues of $718.72 million for the quarter. Net sales, excluding precious metals content, of $665.6 million went up 26.3% from $527.0 million in the first quarter of 2011. Constant currency net sales growth, excluding precious metals content, was 28.3%, driven largely by acquisitions, but also supported by internal sales growth, which was notably strong in the U.S.

by RTTNews Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
An administrative law judge has ruled that Minnesota regulators should approve Enbridge Inc.'s proposal to replace its aging Line 3 crude oil pipeline only if the company follows the existing route and not its preferred route. Enbridge has applied to replace its Line 3 pipeline from Alberta with new pipe along its existing route. In Minnesota, the planned route deviates from the existing route. CLICK HERE to see America's 10 Best-Selling Drugs Despite high drug costs, most of the top-selling drugs saw sales gains in 2017 compared to the prior year. A large number of the best-selling drugs are primarily for the treatment and management of cancer, diabetes, inflammatory disorders, and HIV... Most Americans have access to health care, though costs and services vary from state to state. However, higher costs do not necessarily translate into better results. The U.S. continues to be outperformed by other wealthy nations on several measures like life expectancy, disease burden and health...
Follow RTT